FOLFOX-HAIC versus first-line systemic chemotherapy in HBsAg-positive patients with unresectable intrahepatic cholangiocarcinoma: A propensity score matched cohort study

Hepatobiliary & Pancreatic Diseases International · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles